Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.

BACKGROUND:While the effect of highly active antiretroviral therapy (HAART) on natural history of cervical lesions remains controversial, resource limited countries need to understand the relevance of their own data to their settings. We compared the risk of cervical disease in HAART-experienced wom...

Full description

Bibliographic Details
Main Authors: Cavin Epie Bekolo, Gillian O'Bryan, François Edmond Tchago, Charlette Nangue, Patrick Sylvestre Bekoule, Basile Kollo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4750954?pdf=render
_version_ 1828171786378805248
author Cavin Epie Bekolo
Gillian O'Bryan
François Edmond Tchago
Charlette Nangue
Patrick Sylvestre Bekoule
Basile Kollo
author_facet Cavin Epie Bekolo
Gillian O'Bryan
François Edmond Tchago
Charlette Nangue
Patrick Sylvestre Bekoule
Basile Kollo
author_sort Cavin Epie Bekolo
collection DOAJ
description BACKGROUND:While the effect of highly active antiretroviral therapy (HAART) on natural history of cervical lesions remains controversial, resource limited countries need to understand the relevance of their own data to their settings. We compared the risk of cervical disease in HAART-experienced women with that in women in the general population of Cameroon. METHODS:A retrospective cross sectional survey of women aged 35 years and above, attending a voluntary screening campaign for cervical cancer at the Nkongsamba Regional Hospital in Cameroon between February and May 2014. Squamous intraepithelial lesions (SIL) were determined by Pap smear. Multiple logistic regression was used to compare the odds of SIL in women on HAART to women from the community with unknown HIV status. RESULTS:Included were 302 women of whom 131(43.4%) were HIV-infected and receiving HAART on the site while 171 (56.6%) were women from the community. Cervical disease was observed in 51(16.9%) persons of whom 15 (11.5%) cases in the HAART group and 36 (21.1%) cases in the general group (p = 0.027). After controlling for age and other covariates, women in the HAART group had a 67% reduction in the odds of cervical lesions compared with the community group [adjusted odd ratio (aOR) = 0.33, 95%CI: 0.15-0.73, p = 0.006). CONCLUSION:HIV-infected women receiving HAART have a lower risk of cancer than women in the general population. This finding may not be attributed to HAART alone but to all the health benefits derived from receiving a comprehensive HIV care.
first_indexed 2024-04-12T03:31:06Z
format Article
id doaj.art-60a0a970ae614aa89ab4796b1567b62d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T03:31:06Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-60a0a970ae614aa89ab4796b1567b62d2022-12-22T03:49:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01112e014915210.1371/journal.pone.0149152Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.Cavin Epie BekoloGillian O'BryanFrançois Edmond TchagoCharlette NanguePatrick Sylvestre BekouleBasile KolloBACKGROUND:While the effect of highly active antiretroviral therapy (HAART) on natural history of cervical lesions remains controversial, resource limited countries need to understand the relevance of their own data to their settings. We compared the risk of cervical disease in HAART-experienced women with that in women in the general population of Cameroon. METHODS:A retrospective cross sectional survey of women aged 35 years and above, attending a voluntary screening campaign for cervical cancer at the Nkongsamba Regional Hospital in Cameroon between February and May 2014. Squamous intraepithelial lesions (SIL) were determined by Pap smear. Multiple logistic regression was used to compare the odds of SIL in women on HAART to women from the community with unknown HIV status. RESULTS:Included were 302 women of whom 131(43.4%) were HIV-infected and receiving HAART on the site while 171 (56.6%) were women from the community. Cervical disease was observed in 51(16.9%) persons of whom 15 (11.5%) cases in the HAART group and 36 (21.1%) cases in the general group (p = 0.027). After controlling for age and other covariates, women in the HAART group had a 67% reduction in the odds of cervical lesions compared with the community group [adjusted odd ratio (aOR) = 0.33, 95%CI: 0.15-0.73, p = 0.006). CONCLUSION:HIV-infected women receiving HAART have a lower risk of cancer than women in the general population. This finding may not be attributed to HAART alone but to all the health benefits derived from receiving a comprehensive HIV care.http://europepmc.org/articles/PMC4750954?pdf=render
spellingShingle Cavin Epie Bekolo
Gillian O'Bryan
François Edmond Tchago
Charlette Nangue
Patrick Sylvestre Bekoule
Basile Kollo
Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.
PLoS ONE
title Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.
title_full Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.
title_fullStr Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.
title_full_unstemmed Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.
title_short Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.
title_sort integrating cervical cancer screening with hiv care in cameroon comparative risk analysis of cervical disease in hiv infected women receiving antiretroviral therapy to women in the general population
url http://europepmc.org/articles/PMC4750954?pdf=render
work_keys_str_mv AT cavinepiebekolo integratingcervicalcancerscreeningwithhivcareincamerooncomparativeriskanalysisofcervicaldiseaseinhivinfectedwomenreceivingantiretroviraltherapytowomeninthegeneralpopulation
AT gillianobryan integratingcervicalcancerscreeningwithhivcareincamerooncomparativeriskanalysisofcervicaldiseaseinhivinfectedwomenreceivingantiretroviraltherapytowomeninthegeneralpopulation
AT francoisedmondtchago integratingcervicalcancerscreeningwithhivcareincamerooncomparativeriskanalysisofcervicaldiseaseinhivinfectedwomenreceivingantiretroviraltherapytowomeninthegeneralpopulation
AT charlettenangue integratingcervicalcancerscreeningwithhivcareincamerooncomparativeriskanalysisofcervicaldiseaseinhivinfectedwomenreceivingantiretroviraltherapytowomeninthegeneralpopulation
AT patricksylvestrebekoule integratingcervicalcancerscreeningwithhivcareincamerooncomparativeriskanalysisofcervicaldiseaseinhivinfectedwomenreceivingantiretroviraltherapytowomeninthegeneralpopulation
AT basilekollo integratingcervicalcancerscreeningwithhivcareincamerooncomparativeriskanalysisofcervicaldiseaseinhivinfectedwomenreceivingantiretroviraltherapytowomeninthegeneralpopulation